139 related articles for article (PubMed ID: 17188662)
1. Increased 8-OHdG levels in the urine, serum, and substantia nigra of hemiparkinsonian rats.
Yasuhara T; Hara K; Sethi KD; Morgan JC; Borlongan CV
Brain Res; 2007 Feb; 1133(1):49-52. PubMed ID: 17188662
[TBL] [Abstract][Full Text] [Related]
2. Urinary 8-OHdG elevations in a partial lesion rat model of Parkinson's disease correlate with behavioral symptoms and nigrostriatal dopaminergic depletion.
Kikuchi Y; Yasuhara T; Agari T; Kondo A; Kuramoto S; Kameda M; Kadota T; Baba T; Tajiri N; Wang F; Tayra JT; Liang H; Miyoshi Y; Borlongan CV; Date I
J Cell Physiol; 2011 May; 226(5):1390-8. PubMed ID: 20945350
[TBL] [Abstract][Full Text] [Related]
3. Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy.
Kikuchi A; Takeda A; Onodera H; Kimpara T; Hisanaga K; Sato N; Nunomura A; Castellani RJ; Perry G; Smith MA; Itoyama Y
Neurobiol Dis; 2002 Mar; 9(2):244-8. PubMed ID: 11895375
[TBL] [Abstract][Full Text] [Related]
4. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
[TBL] [Abstract][Full Text] [Related]
5. Peripheral oxidative biomarkers constitute a valuable indicator of the severity of oxidative brain damage in acute cerebral infarction.
Liu H; Uno M; Kitazato KT; Suzue A; Manabe S; Yamasaki H; Shono M; Nagahiro S
Brain Res; 2004 Oct; 1025(1-2):43-50. PubMed ID: 15464743
[TBL] [Abstract][Full Text] [Related]
6. Induction of GAP-43 modulates neuroplasticity in PBSC (CD34+) implanted-Parkinson's model.
Shyu WC; Li KW; Peng HF; Lin SZ; Liu RS; Wang HJ; Su CY; Lee YJ; Li H
J Neurosci Res; 2009 Jul; 87(9):2020-33. PubMed ID: 19235891
[TBL] [Abstract][Full Text] [Related]
7. In vivo 6-OHDA-induced neurodegeneration and nigral autophagic markers expression.
Marin C; Aguilar E
Neurochem Int; 2011 Mar; 58(4):521-6. PubMed ID: 21237229
[TBL] [Abstract][Full Text] [Related]
8. Effect of unilateral lesion of the nigrostriatal dopamine pathway on survival and neurochemistry of parafascicular nucleus neurons in the rat--evaluation of time-course and LGR8 expression.
Sedaghat K; Finkelstein DI; Gundlach AL
Brain Res; 2009 May; 1271():83-94. PubMed ID: 19328193
[TBL] [Abstract][Full Text] [Related]
9. Urinary marker for oxidative stress in kidneys in cisplatin-induced acute renal failure in rats.
Zhou H; Kato A; Miyaji T; Yasuda H; Fujigaki Y; Yamamoto T; Yonemura K; Takebayashi S; Mineta H; Hishida A
Nephrol Dial Transplant; 2006 Mar; 21(3):616-23. PubMed ID: 16384831
[TBL] [Abstract][Full Text] [Related]
10. Ferroportin1 and hephaestin are involved in the nigral iron accumulation of 6-OHDA-lesioned rats.
Wang J; Jiang H; Xie JX
Eur J Neurosci; 2007 May; 25(9):2766-72. PubMed ID: 17561842
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress and dopamine depletion in an intrastriatal 6-hydroxydopamine model of Parkinson's disease.
Smith MP; Cass WA
Neuroscience; 2007 Feb; 144(3):1057-66. PubMed ID: 17110046
[TBL] [Abstract][Full Text] [Related]
12. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.
Aponso PM; Faull RL; Connor B
Neuroscience; 2008 Feb; 151(4):1142-53. PubMed ID: 18201835
[TBL] [Abstract][Full Text] [Related]
13. 8-OHdG in cerebrospinal fluid as a marker of oxidative stress in various neurodegenerative diseases.
Gmitterová K; Heinemann U; Gawinecka J; Varges D; Ciesielczyk B; Valkovic P; Benetin J; Zerr I
Neurodegener Dis; 2009; 6(5-6):263-9. PubMed ID: 19955696
[TBL] [Abstract][Full Text] [Related]
14. [Urinary 8-hydroxy-2'-deoxyguanosine: a biomarker of environmental oxidative stress?].
Sajous L; Botta A; Sari-Minodier I
Ann Biol Clin (Paris); 2008; 66(1):19-29. PubMed ID: 18227001
[TBL] [Abstract][Full Text] [Related]
15. Plasma and urinary HPLC-ED determination of the ratio of 8-OHdG/2-dG in Parkinson's disease.
Bolner A; Pilleri M; De Riva V; Nordera GP
Clin Lab; 2011; 57(11-12):859-66. PubMed ID: 22239015
[TBL] [Abstract][Full Text] [Related]
16. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.
Bustos G; Abarca J; Bustos V; Riquelme E; Noriega V; Moya C; Campusano J
J Neurosci Res; 2009 Aug; 87(10):2308-18. PubMed ID: 19326433
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin reverses the downregulation of dopamine D1 and D2 receptor expression in the prefrontal cortex of 6-hydroxydopamine-induced Parkinsonian rats.
Wang Q; Wang PH; McLachlan C; Wong PT
Brain Res; 2005 May; 1045(1-2):229-33. PubMed ID: 15910782
[TBL] [Abstract][Full Text] [Related]
18. High frequency stimulation of the subthalamic nucleus improves speed of locomotion but impairs forelimb movement in Parkinsonian rats.
Vlamings R; Visser-Vandewalle V; Koopmans G; Joosten EA; Kozan R; Kaplan S; Steinbusch HW; Temel Y
Neuroscience; 2007 Sep; 148(3):815-23. PubMed ID: 17706885
[TBL] [Abstract][Full Text] [Related]
19. Proteomic identification of biomarkers in the cerebrospinal fluid in a rat model of nigrostriatal dopaminergic degeneration.
Rite I; Argüelles S; Venero JL; García-Rodriguez S; Ayala A; Cano J; Machado A
J Neurosci Res; 2007 Dec; 85(16):3607-18. PubMed ID: 17705290
[TBL] [Abstract][Full Text] [Related]
20. Intracellular signaling pathways involved in post-mitotic dopaminergic PC12 cell death induced by 6-hydroxydopamine.
Rodriguez-Blanco J; Martín V; Herrera F; García-Santos G; Antolín I; Rodriguez C
J Neurochem; 2008 Oct; 107(1):127-40. PubMed ID: 18665912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
